A citation-based method for searching scientific literature

Daniella Balduino Victorino, Mariana Nejm, Marcia Guimarães-Marques, Fulvio Alexandre Scorza, Carla Alessandra Scorza. Pharmaceut Med 2021
Times Cited: 2







List of co-cited articles
5 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



GLP-1 receptor localization in monkey and human tissue: novel distribution revealed with extensively validated monoclonal antibody.
Charles Pyke, R Scott Heller, Rikke K Kirk, Cathrine Ørskov, Steffen Reedtz-Runge, Peter Kaastrup, Anders Hvelplund, Linda Bardram, Dan Calatayud, Lotte Bjerre Knudsen. Endocrinology 2014
452
100

Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study.
Matthew James Armstrong, Piers Gaunt, Guruprasad P Aithal, Darren Barton, Diana Hull, Richard Parker, Jonathan M Hazlehurst, Kathy Guo, George Abouda, Mark A Aldersley,[...]. Lancet 2016
944
100

Semaglutide lowers body weight in rodents via distributed neural pathways.
Sanaz Gabery, Casper G Salinas, Sarah J Paulsen, Jonas Ahnfelt-Rønne, Tomas Alanentalo, Arian F Baquero, Stephen T Buckley, Erzsébet Farkas, Csaba Fekete, Klaus S Frederiksen,[...]. JCI Insight 2020
121
100

A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis.
Philip N Newsome, Kristine Buchholtz, Kenneth Cusi, Martin Linder, Takeshi Okanoue, Vlad Ratziu, Arun J Sanyal, Anne-Sophie Sejling, Stephen A Harrison. N Engl J Med 2021
357
100

The Neuroprotection of Liraglutide Against Ischaemia-induced Apoptosis through the Activation of the PI3K/AKT and MAPK Pathways.
Huili Zhu, Yusheng Zhang, Zhongshan Shi, Dan Lu, Tingting Li, Yan Ding, Yiwen Ruan, Anding Xu. Sci Rep 2016
124
50



Hypertension.
Suzanne Oparil, Maria Czarina Acelajado, George L Bakris, Dan R Berlowitz, Renata Cífková, Anna F Dominiczak, Guido Grassi, Jens Jordan, Neil R Poulter, Anthony Rodgers,[...]. Nat Rev Dis Primers 2018
332
50

Effect of liraglutide on ectopic fat in polycystic ovary syndrome: A randomized clinical trial.
Signe Frøssing, Malin Nylander, Elizaveta Chabanova, Jan Frystyk, Jens J Holst, Caroline Kistorp, Sven O Skouby, Jens Faber. Diabetes Obes Metab 2018
61
50

SIRT1/HSF1/HSP pathway is essential for exenatide-alleviated, lipid-induced hepatic endoplasmic reticulum stress.
Xiaobin Zheng, Fen Xu, Hua Liang, Huanyi Cao, Mengyin Cai, Wen Xu, Jianping Weng. Hepatology 2017
46
50

Liraglutide Alleviates Hepatic Steatosis by Activating the TFEB-Regulated Autophagy-Lysosomal Pathway.
Yunyun Fang, Linlin Ji, Chaoyu Zhu, Yuanyuan Xiao, Jingjing Zhang, Junxi Lu, Jun Yin, Li Wei. Front Cell Dev Biol 2020
28
50


Blood pressure-lowering effects of GLP-1 receptor agonists exenatide and liraglutide: a meta-analysis of clinical trials.
B Wang, J Zhong, H Lin, Z Zhao, Z Yan, H He, Y Ni, D Liu, Z Zhu. Diabetes Obes Metab 2013
135
50


Non-alcoholic fatty liver disease (NAFLD) and risk of hospitalization for Covid-19.
Carolyn Bramante, Christopher J Tignanelli, Nirjhar Dutta, Emma Jones, Leonardo Tamariz, Jeanne M Clark, Michael Usher, Genevieve Metlon-Meaux, Sayeed Ikramuddin. medRxiv 2020
35
50

The non-peptide GLP-1 receptor agonist WB4-24 blocks inflammatory nociception by stimulating β-endorphin release from spinal microglia.
Hui Fan, Nian Gong, Teng-Fei Li, Ai-Niu Ma, Xiao-Yan Wu, Ming-Wei Wang, Yong-Xiang Wang. Br J Pharmacol 2015
47
50

Pharmacological management of nonalcoholic fatty liver disease.
Diana Barb, Paola Portillo-Sanchez, Kenneth Cusi. Metabolism 2016
68
50

Dulaglutide ameliorates STZ induced AD-like impairment of learning and memory ability by modulating hyperphosphorylation of tau and NFs through GSK3β.
Mei Zhou, Shuyi Chen, Peng Peng, Zhongya Gu, Jing Yu, Gang Zhao, Yanqiu Deng. Biochem Biophys Res Commun 2019
25
50

Obesity, Polycystic Ovary Syndrome, and Infertility: A New Avenue for GLP-1 Receptor Agonists.
Hellas Cena, Luca Chiovato, Rossella E Nappi. J Clin Endocrinol Metab 2020
41
50



Glucagon like peptide-1 (GLP-1) likes Alzheimer's disease.
Ilgin Yildirim Simsir, Utku Erdem Soyaltin, Sevki Cetinkalp. Diabetes Metab Syndr 2018
38
50

Use of incretin agents and risk of pancreatic cancer: a population-based cohort study.
L M Knapen, J van Dalem, Y C Keulemans, N P van Erp, M T Bazelier, M L De Bruin, H G M Leufkens, S Croes, C Neef, F de Vries,[...]. Diabetes Obes Metab 2016
23
50

GLP-1 receptor agonists in NAFLD.
J-M Petit, B Vergès. Diabetes Metab 2017
30
50

Implications of the local haemodynamic forces on the phenotype of coronary plaques.
Christos V Bourantas, Thomas Zanchin, Antonis Sakellarios, Alexios Karagiannis, Anantharaman Ramasamy, Kyohei Yamaji, Masanori Taniwaki, Dik Heg, Aris Moschovitis, Dimitrios Fotiadis,[...]. Heart 2019
9
50

Do GLP-1 Receptor Agonists Increase the Risk of Breast Cancer? A Systematic Review and Meta-analysis.
Giovana F Piccoli, Leonardo A Mesquita, Cinara Stein, Marina Aziz, Maira Zoldan, Nathália A H Degobi, Bernardo F Spiazzi, Gilberto L Lopes Junior, Verônica Colpani, Fernando Gerchman. J Clin Endocrinol Metab 2021
9
50

Neuroprotective effects of liraglutide for stroke model of rats.
Kenichiro Sato, Masahiro Kameda, Takao Yasuhara, Takashi Agari, Tanefumi Baba, Feifei Wang, Aiko Shinko, Takaaki Wakamori, Atsuhiko Toyoshima, Hayato Takeuchi,[...]. Int J Mol Sci 2013
85
50



Novel GLP-1 mimetics developed to treat type 2 diabetes promote progenitor cell proliferation in the brain.
A Hamilton, S Patterson, D Porter, V A Gault, C Holscher. J Neurosci Res 2011
155
50

Epidemiology of cardiovascular disease in China: current features and implications.
Dong Zhao, Jing Liu, Miao Wang, Xingguang Zhang, Mengge Zhou. Nat Rev Cardiol 2019
368
50

GLP-1 analogue prevents NAFLD in ApoE KO mice with diet and Acrp30 knockdown by inhibiting c-JNK.
Lili Zhang, Mengliu Yang, Hong Ren, Huaidong Hu, Guenther Boden, Ling Li, Gangyi Yang. Liver Int 2013
45
50


Polycystic ovary syndrome.
Ricardo Azziz, Enrico Carmina, ZiJiang Chen, Andrea Dunaif, Joop S E Laven, Richard S Legro, Daria Lizneva, Barbara Natterson-Horowtiz, Helena J Teede, Bulent O Yildiz. Nat Rev Dis Primers 2016
596
50

Activation of glucagon-like peptide-1 receptor inhibits growth and promotes apoptosis of human pancreatic cancer cells in a cAMP-dependent manner.
Hejun Zhao, Rui Wei, Liang Wang, Qing Tian, Ming Tao, Jing Ke, Ye Liu, Wenfang Hou, Lin Zhang, Jin Yang,[...]. Am J Physiol Endocrinol Metab 2014
26
50

The amyloid hypothesis on trial.
Simon Makin. Nature 2018
173
50

Stroke.
Graeme J Hankey. Lancet 2017
605
50

Targeting glucose-dependent insulinotropic polypeptide receptor for neurodegenerative disorders.
Mahip K Verma, Rajan Goel, Nandakumar Krishnadas, Kumar V S Nemmani. Expert Opin Ther Targets 2018
14
50

Structural basis for GLP-1 receptor activation by LY3502970, an orally active nonpeptide agonist.
Takahiro Kawai, Bingfa Sun, Hitoshi Yoshino, Dan Feng, Yoshiyuki Suzuki, Masanori Fukazawa, Shunsuke Nagao, David B Wainscott, Aaron D Showalter, Brian A Droz,[...]. Proc Natl Acad Sci U S A 2020
27
50


Effective oral delivery of Exenatide-Zn2+ complex through distal ileum-targeted double layers nanocarriers modified with deoxycholic acid and glycocholic acid in diabetes therapy.
Ying Han, Wei Liu, Liqing Chen, Xin Xin, Qiming Wang, Xintong Zhang, Mingji Jin, Zhonggao Gao, Wei Huang. Biomaterials 2021
2
50

The glucagon-like peptide 1 receptor agonist exendin-4 improves reference memory performance and decreases immobility in the forced swim test.
Ruben Isacson, Elisabet Nielsen, Karin Dannaeus, Göran Bertilsson, Cesare Patrone, Olof Zachrisson, Lilian Wikström. Eur J Pharmacol 2011
105
50

GLP-1 receptor agonists for Parkinson's disease.
Caroline A Mulvaney, Gonçalo S Duarte, Joel Handley, David Jw Evans, Suresh Menon, Richard Wyse, Hedley Ca Emsley. Cochrane Database Syst Rev 2020
19
50

An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease- associated Aβ oligomers.
Theresa R Bomfim, Leticia Forny-Germano, Luciana B Sathler, Jordano Brito-Moreira, Jean-Christophe Houzel, Helena Decker, Michael A Silverman, Hala Kazi, Helen M Melo, Paula L McClean,[...]. J Clin Invest 2012
594
50



Long non-coding RNA lnc-CCNL1-3:1 promotes granulosa cell apoptosis and suppresses glucose uptake in women with polycystic ovary syndrome.
Jiayu Huang, Jun Zhao, Xueying Geng, Weiwei Chu, Shang Li, Zi-Jiang Chen, Yanzhi Du. Mol Ther Nucleic Acids 2020
10
50

GLP-1/GLP-1R Signaling Regulates Ovarian PCOS-Associated Granulosa Cells Proliferation and Antiapoptosis by Modification of Forkhead Box Protein O1 Phosphorylation Sites.
Zhihua Sun, Peiyi Li, Xiao Wang, Shuchang Lai, Hong Qiu, Zhi Chen, Shidi Hu, Jie Yao, Jie Shen. Int J Endocrinol 2020
5
50



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.